|Day Low/High||1.50 / 1.83|
|52 Wk Low/High||1.37 / 3.85|
Upgrades: KORS, QADA, TTEK, WD Downgrades: AOSL, APC, BIG, CSH, DGSE, GSJK, QGEN, SYK, TDG, TTS, UAN, UWN, ZOLT, ZX Initiations: XTLB Read on to get TheStreet Quant Ratings' detailed report:
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
XTL Biopharma slips after suspending development of its hepatitis C treatment.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.